AU752714B2 - Combined preparation of anti-infectiously active compounds which inhibit the 2-C-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism - Google Patents
Combined preparation of anti-infectiously active compounds which inhibit the 2-C-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism Download PDFInfo
- Publication number
- AU752714B2 AU752714B2 AU46155/99A AU4615599A AU752714B2 AU 752714 B2 AU752714 B2 AU 752714B2 AU 46155/99 A AU46155/99 A AU 46155/99A AU 4615599 A AU4615599 A AU 4615599A AU 752714 B2 AU752714 B2 AU 752714B2
- Authority
- AU
- Australia
- Prior art keywords
- substituted
- unsubstituted
- alkyl
- radicals
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19828097A DE19828097A1 (de) | 1998-06-24 | 1998-06-24 | Kombinationspräparat von Aminohydrocarbylphosphonsäurederivaten und Hemmern des Fettstoffwechsels |
DE19828097 | 1998-06-24 | ||
DE19843279 | 1998-09-22 | ||
DE19843279 | 1998-09-22 | ||
PCT/EP1999/004360 WO1999066875A2 (de) | 1998-06-24 | 1999-06-23 | Kombinationspräparat von antiinfektiös wirkenden verbindungen, die den 2-c-methylerythrose-4-stoffwechselweg hemmen, und hemmern des fettstoffwechsels |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4615599A AU4615599A (en) | 2000-01-10 |
AU752714B2 true AU752714B2 (en) | 2002-09-26 |
Family
ID=26047010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU46155/99A Ceased AU752714B2 (en) | 1998-06-24 | 1999-06-23 | Combined preparation of anti-infectiously active compounds which inhibit the 2-C-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1100510A2 (de) |
JP (1) | JP2002518418A (de) |
CN (1) | CN1348374A (de) |
AU (1) | AU752714B2 (de) |
CA (1) | CA2334645A1 (de) |
IL (1) | IL139965A0 (de) |
PL (1) | PL345513A1 (de) |
SK (1) | SK19612000A3 (de) |
TR (1) | TR200003783T2 (de) |
WO (1) | WO1999066875A2 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7132268B2 (en) | 1998-04-14 | 2006-11-07 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
WO2015127259A1 (en) * | 2014-02-23 | 2015-08-27 | Fmc Corporation | Use of 3-isoxazolidinones compounds as selective herbicides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4330529A (en) * | 1978-02-15 | 1982-05-18 | Fujisawa Pharmaceutical Co., Ltd. | Antibacterial composition |
JPS6064991A (ja) * | 1983-09-17 | 1985-04-13 | Fujisawa Pharmaceut Co Ltd | セファレキシン・ホスミドマイシン塩およびその製造法 |
US4846872A (en) * | 1986-08-11 | 1989-07-11 | Fujisawa Pharmaceutical Co., Ltd. | Herbicide |
JPH05163150A (ja) * | 1991-05-13 | 1993-06-29 | E R Squibb & Sons Inc | アテローム性動脈硬化症の抑制・治療剤 |
ATE129407T1 (de) * | 1991-10-11 | 1995-11-15 | Squibb & Sons Inc | Verwendung von biphosphonaten zur herstellung eines arzneimittels zur blockierung neoplastischer zelltransformationen die durch ras-oncogene verursacht werden. |
-
1999
- 1999-06-23 EP EP99929309A patent/EP1100510A2/de not_active Withdrawn
- 1999-06-23 CN CN99809991A patent/CN1348374A/zh active Pending
- 1999-06-23 WO PCT/EP1999/004360 patent/WO1999066875A2/de not_active Application Discontinuation
- 1999-06-23 AU AU46155/99A patent/AU752714B2/en not_active Ceased
- 1999-06-23 JP JP2000555562A patent/JP2002518418A/ja active Pending
- 1999-06-23 PL PL99345513A patent/PL345513A1/xx unknown
- 1999-06-23 CA CA002334645A patent/CA2334645A1/en not_active Abandoned
- 1999-06-23 TR TR2000/03783T patent/TR200003783T2/xx unknown
- 1999-06-23 SK SK1961-2000A patent/SK19612000A3/sk unknown
- 1999-06-23 IL IL13996599A patent/IL139965A0/xx unknown
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7132268B2 (en) | 1998-04-14 | 2006-11-07 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
US7208298B2 (en) | 1998-04-14 | 2007-04-24 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
US7364885B2 (en) | 1998-04-14 | 2008-04-29 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
US7531333B2 (en) | 1998-04-14 | 2009-05-12 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
WO2015127259A1 (en) * | 2014-02-23 | 2015-08-27 | Fmc Corporation | Use of 3-isoxazolidinones compounds as selective herbicides |
EA029969B1 (ru) * | 2014-02-23 | 2018-06-29 | Фмк Корпорейшн | Применение 3-изоксазолидиноновых соединений в качестве селективных гербицидов |
Also Published As
Publication number | Publication date |
---|---|
EP1100510A2 (de) | 2001-05-23 |
CA2334645A1 (en) | 1999-12-29 |
AU4615599A (en) | 2000-01-10 |
IL139965A0 (en) | 2002-02-10 |
TR200003783T2 (tr) | 2001-06-21 |
PL345513A1 (en) | 2001-12-17 |
JP2002518418A (ja) | 2002-06-25 |
CN1348374A (zh) | 2002-05-08 |
SK19612000A3 (sk) | 2001-08-06 |
WO1999066875A2 (de) | 1999-12-29 |
WO1999066875A3 (de) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU747407B2 (en) | Use of organophosphoric compounds for the therapeutic and preventative treatment of infections | |
US6812224B2 (en) | Phosphorous organic compounds and their use | |
US6753324B2 (en) | Phosphorous organic compounds and their use | |
AU752714B2 (en) | Combined preparation of anti-infectiously active compounds which inhibit the 2-C-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism | |
AU5981199A (en) | Use of organophosphorous compounds for producing medicaments for the therapeuticand prophylactic treatment of infections or as a fungicide, bactericide or herb icide for plants | |
CA2360661A1 (en) | Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections | |
CA2399947A1 (en) | Phosphororganic compounds and the use thereof | |
US20030144249A1 (en) | Use of organophosphorous compounds for producing a medicament for treating infections | |
WO2000017212A1 (de) | Phosphororganische verbindungen und ihre verwendung | |
CZ20004797A3 (cs) | Kombinovaný přípravek antiinfekčně působících sloučenin, které inhibují metabolickou dráhu 2- C-methylerythrosy-4, a inhibitorů metabolismu lipidů | |
AU2003261554A1 (en) | Organophosphorus containing preparations and applications therefor | |
CZ2001989A3 (cs) | Použití fosfororganických sloučenin pro výrobu léčiv pro terapeutické a profylaktické ošetřování infekcí nebo jako fungicid, baktericid či herbicid u rostlin | |
MXPA01000488A (en) | Phosphorous organic compounds and their use | |
CZ20003499A3 (cs) | Použití organofosforových sloučenin k léčbě a profylaxi infekcí | |
MXPA01002979A (en) | Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants | |
CZ2001151A3 (cs) | Fosfororganické sloučeniny a jejich použití |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC1 | Assignment before grant (sect. 113) |
Owner name: JOMAA PHARMAKA GMBH Free format text: THE FORMER OWNER WAS: JOMAA HASSAN |
|
FGA | Letters patent sealed or granted (standard patent) | ||
PC | Assignment registered |
Owner name: BIOAGENCY AG Free format text: FORMER OWNER WAS: JOMAA PHARMAKA GMBH |